The Effects of Human Papillomavirus Infection and Vaccination on Cardiovascular Diseases, NHANES 2003-2016

被引:12
|
作者
Liang, Xiaopeng [1 ]
Chou, Oscar Hou In [1 ]
Cheung, Bernard M. Y. [1 ,2 ,3 ,4 ]
机构
[1] Univ Hong Kong, Sch Clin Med, Dept Med, Div Clin Pharmacol & Therapeut, Hong Kong, Peoples R China
[2] Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Pokfulam, Hong Kong, Peoples R China
[3] Univ Hong Kong, Inst Cardiovasc Sci & Med, Pokfulam, Hong Kong, Peoples R China
[4] Queen Mary Hosp, Dept Med, Sch Clin Med, 102 Pokfulam Rd, Hong Kong, Peoples R China
关键词
Cardiovascular diseases; Coronary heart diseases; Human papillomavirus infection; HPV vaccination; Vaccination; NUTRITION EXAMINATION SURVEY; NATIONAL-HEALTH; BLOOD-PRESSURE; UNITED-STATES; RISK-FACTORS; DOUBLE-BLIND; INFLAMMATION; PREVALENCE; EFFICACY; IMPACT;
D O I
10.1016/j.amjmed.2022.09.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Human papillomavirus (HPV) infection has been proposed to be an unconventional risk factor for cardiovascular diseases. We investigated the association between HPV infection and cardiovas-cular diseases among women with or without HPV vaccination.METHODS: This cross-sectional study included 9,353 women aged between 20 to 59 years old who were tested for vaginal HPV DNA in the National Health and Nutrition Examination Survey (NHANES) 2003-2016. Cardiovascular diseases were defined as the presence of self-reported coronary heart diseases, heart attacks, angina pectoris, and stroke. The association between HPV and cardiovascular diseases was studied using logistic regression, with adjustment for the potential confounders.RESULTS: A total of 40.8% of women were HPV DNA positive; 3.0% had cardiovascular diseases; and 9.0% of women received the HPV vaccine. The presence of vaginal HPV infection was associated with cardiovascular diseases (odd ratio [OR] = 1.66, 95% confidence interval [CI] 1.28-2.16), which remained significant (OR = 1.54, 95% CI 1.15-2.08) after adjustment for sociodemographic characteristics, lifestyle behaviors, medical history, family history of cardiovascular diseases, and antihypertensive drugs. The association was absent among those who were vaccinated against HPV (OR= 0.50, 95% CI 0.07-3.51) but present among those who were not (OR = 1.63, 95% CI 1.18-2.25).CONCLUSIONS: There was an association between HPV infection and cardiovascular diseases. This associ-ation was not significant among women vaccinated against HPV. The effect of HPV vaccination on cardio-vascular diseases requires further investigation.(c) 2022 Elsevier Inc. All rights reserved. center dot The American Journal of Medicine (2023) 136:294-301
引用
收藏
页码:294 / 301.e2
页数:10
相关论文
共 50 条
  • [41] Effective vaccination strategies for human papillomavirus (HPV) infection and cervical cancer based on the mathematical model with a stochastic process
    Kim, Minsoo
    Kim, Eunjung
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (04)
  • [42] High-Risk Human Papillomavirus Infection and the Risk of Cardiovascular Disease in Korean Women A Cohort Study
    Joo, Eun-Jeong
    Chang, Yoosoo
    Kwon, Min-Jung
    Cho, Ara
    Cheong, Hae Suk
    Ryu, Seungho
    CIRCULATION RESEARCH, 2019, 124 (05) : 747 - 756
  • [43] Vaccination strategies in a pair formation model for human papillomavirus infection: An optimal control approach
    Saldana, Fernando
    JOURNAL OF THEORETICAL BIOLOGY, 2025, 597
  • [44] Awareness, knowledge and attitudes of human papillomavirus infection, screening and vaccination: a survey study in Greece
    Pergialiotis, Vasilios
    Papageorgiou, Dimitrios
    Douligeris, Athanasios
    Mortaki, Anastasia
    Vlachos, Dimitrios Efthymios
    Thomakos, Nikolaos
    Rodolakis, Alexandros
    Haidopoulos, Dimitrios
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2024, 309 (05) : 2031 - 2040
  • [45] Prevalence of Oral Human Papillomavirus Infection: Impact of Sex, Race/Ethnicity, and Vaccination Status
    Berenson, Abbey B.
    Hirth, Jacqueline M.
    Chang, Mihyun
    CLINICAL INFECTIOUS DISEASES, 2022, 74 (07) : 1230 - 1236
  • [46] The Direct Medical Costs of Diseases Associated with Human Papillomavirus Infection in Manitoba, Canada
    Righolt, Christiaan H.
    Pabla, Gurpreet
    Mahmud, Salaheddin M.
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2018, 16 (02) : 195 - 205
  • [47] A two-sex model of human papillomavirus infection: Vaccination strategies and a case study
    Gao, Shasha
    Martcheva, Maia
    Miao, Hongyu
    Rong, Libin
    JOURNAL OF THEORETICAL BIOLOGY, 2022, 536
  • [48] Awareness, knowledge and attitudes of human papillomavirus infection, screening and vaccination: a survey study in Greece
    Vasilios Pergialiotis
    Dimitrios Papageorgiou
    Athanasios Douligeris
    Anastasia Mortaki
    Dimitrios Efthymios Vlachos
    Nikolaos Thomakos
    Alexandros Rodolakis
    Dimitrios Haidopoulos
    Archives of Gynecology and Obstetrics, 2024, 309 : 2031 - 2040
  • [49] Parents' views on human papillomavirus vaccination for sexually transmissible infection prevention: a qualitative study
    Niccolai, Linda M.
    Hansen, Caitlin E.
    Credle, Marisol
    Ryan, Sheryl A.
    Shapiro, Eugene D.
    SEXUAL HEALTH, 2014, 11 (03) : 274 - 279
  • [50] Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases
    Hviid, A.
    Svanstrom, H.
    Scheller, N. M.
    Gronlund, O.
    Pasternak, B.
    Arnheim-Dahlstrom, L.
    JOURNAL OF INTERNAL MEDICINE, 2018, 283 (02) : 154 - 165